|
|
楼主 |
发表于 2026-2-8 12:09:30
|
显示全部楼层
Retrospective Quality Assessment of Lyophilized Rabies Vaccine by Vero Cell for Human Use
# s. v' y2 Q2 ]9 g2 t, ]Chunhui He, Haolin Fang, Yebo Li, Ting Zhou, Mingjian Chen, Lefeng Zhang, Qi Zhao, Huiyu Yu, Zihang Xu, Jieping Liu2 ]% W7 e8 J- N, G, k( H0 k, P
9 m. ?: W& Z. D' ]" x5 K
Abstract
: T+ J8 ~1 h2 x8 k/ F! y* _( `- {+ O' |+ |! q; e
Objective: A retrospective analysis of critical quality attributes was conducted to evaluate product quality and manufacturing process control capability of lyophilized rabies vaccine (Vero cell) for human use during 2014-2018. Methods: Statistical analysis was performed on three critical quality evaluation parameters: potency assay, residual bovine serum albumin content, and moisture content. Quality trends and batch-to-batch consistency were assessed by integrating these results with the company's annual process performance index. Results & Conclusion: All critical parameter test results, including potency, residual bovine serum albumin, and moisture content, conformed to standard specifications. Most results remained within annual mean ±3SD, indicating favorable inter-lot consistency. All process performance index values were ≥1.33, demonstrating adequate process control capability.
x7 H! e7 U4 l& n1 [1 `$ w* R- P6 X+ b* b( M
6 C( i0 S t5 f! f3 q# h- f
Keywords
4 E8 S' O! _ S( y( @2 o5 o4 p6 x0 f a4 Y4 m+ ^4 P
Rabies, Rabies Vaccine, Quality Analysis2 B1 Y% O/ m: C( r
& Q- G, h# s& L2 U2 S
1 Z x$ x2 m% T9 k- Z
Full Text:[size=0.85em]PDF
2 I& m) _: [; {# _6 t% } M! \- N5 [. ?
" f2 p( d* ]& R$ XDOI: https://doi.org/10.21092/jav.v14i3.121
d# y! ?6 L0 V' ^4 I# U7 s2 ^% X9 a/ f. O# ?! @" u
|
|